In this file
Comparing alternatives to Ivy Rx is easier when you first identify what needs to change. IvyRx’s broad starting figures and separate microdosing promotion describe more than one possible purchase. Decide which treatment and care arrangement is actually being proposed before comparing alternatives.
The provider’s current comparison point is: A broad starting offer needs to be tied to a particular GLP-1 plan. The entries below offer different care and payment arrangements to examine against that point.
How to use this shortlist
CoreAge Rx is listed first under a commercial partnership. The first position is predetermined by that relationship, and links may earn compensation. It is not an independent finding that CoreAge has the safest medicine, the lowest total price, or the strongest patient outcomes.
Use Ivy Rx’s documented arrangement as the baseline, then test the alternatives against a defined plan after the starting offer. We compare public care descriptions and payment terms. We have not purchased treatment, audited every professional license, or timed the support response. Use the linked source notes and obtain a current personal quote.
01. CoreAge Rx · sponsored first position
This is the paid featured reference for the question in this guide. Its placement does not establish that every feature discussed here is available through its program. Ask about the exact product and care access before assuming a match.
CoreAge Rx provides an online route to medical assessment and, where a clinician prescribes, pharmacy fulfillment. The service is our paid featured partner. That commercial relationship buys its prominent position here; it does not establish a better medicine, a better outcome, or suitability for any particular reader.
The sale offer shows starting equivalents of $99 for semaglutide and $149 for tirzepatide, without a separate membership charge. Its billing explanation uses a three-month example: $149 per month becomes a single $447 payment. A reader should obtain the duration and total for the selected prescription rather than assuming that the smaller figure is charged monthly.
A question to put to the provider: Can you send the full payment schedule and the name of my dispensing pharmacy before I accept the offer?
Read the CoreAge Rx provider file and cost explanation for the connected details.
02. NiceRx
The comparison point for NiceRx: The ongoing price is higher than the introductory month.
NiceRx describes self-pay weight care with provider access, medicine, and shipping included. The page states that insurance is not accepted for this program and that access depends on location and treatment.
Semaglutide is listed at $99 initially and $199 monthly afterward; tirzepatide is $199 initially and $299 thereafter. Use the continuing charge for a recurring budget rather than extending the first-month discount indefinitely.
A question to put to the provider: When must an email cancellation arrive to stop the next order, and has any medication already been dispensed?
The NiceRx alternatives guide examines this arrangement in more detail. You can also consult the official provider page.
03. Brightmeds
The comparison point for Brightmeds: A seasonal three-month promotion differs from the single-month plan.
Brightmeds’ campaign describes provider visits, medication, and delivery within the offer, without a membership fee. Its monthly arrangement is described as automatically renewing.
The Summer Special page lists semaglutide at $297 for three months or $129 for one month; tirzepatide is $357 for three months or $149 for one. The $99 and $119 monthly equivalents belong to the prepaid campaign.
A question to put to the provider: Is the campaign still eligible for my prescription, and at what rate will the plan renew?
The Brightmeds alternatives guide examines this arrangement in more detail. You can also consult the official provider page.
04. Lean Meds
The comparison point for Lean Meds: No automatic rebilling and a described membership need a clear renewal explanation.
LeanMeds describes a self-pay membership with consultations, care planning, prescribed fulfillment, shipping, and individual coaching. Other insurance-related wording should be resolved before assuming coverage.
Plans are advertised from $49 per month with same-price-at-every-dose and no-auto-rebill claims. Ask for the medicine, full term, and manual or recurring steps that authorize the next payment.
A question to put to the provider: Who initiates the renewal, and is any part of this plan actually submitted to insurance?
The Lean Meds alternatives guide examines this arrangement in more detail. You can also consult the official provider page.
05. Henry Meds
The comparison point for Henry Meds: The treatment route and remaining commitment affect the meaning of the starting price.
Henry Meds describes an intake followed by a healthcare-provider assessment and a prescription shipment when appropriate. The service presents visits, medication, and supplies as a bundle, while offering more than one route and program duration.
Its weight-management FAQ advertises GLP-1 care beginning at $179 per month. That figure depends on the selected plan and prescription. A compounded oral preparation and an injection should have separate quotes and separate clinical discussions; one low starting figure cannot describe them both reliably.
A question to put to the provider: What remains payable if I stop this specific plan, and which clinical services continue during the paid term?
Read the Henry Meds provider file and cost explanation for the connected details.
06. Ro
The comparison point for Ro: A Body membership fee is additional to the medicine.
Ro’s Body program describes access to branded GLP-1 treatment and assistance with coverage. Clinical review, the program subscription, and prescription fulfillment are connected steps, but they are not necessarily charged by the same organization.
The listed Body offer is $39 for the first month, followed by $149 on the monthly arrangement. Annual prepayment can reduce the advertised monthly equivalent to $74. Medication is excluded from those membership figures and requires its own covered or cash-pay price.
A question to put to the provider: What will I pay for membership while insurance is being reviewed, and what is the total if the drug is not covered?
Read the Ro provider file and cost explanation for the connected details.
Your starting point: Ivy Rx
IvyRx describes online medical assessment and delivery after prescribing. It also markets a separate microdosing offer, so different treatment goals and price blocks should not be mixed.
The weight-loss page includes a $77 starting promotion. It does not establish a complete continuing price for every treatment. The FAQ advertises no long contracts or cancellation fees, but the precise prescription and next payment still need confirmation.
Which treatment does the starting figure buy, and what will I pay for its later supply and clinical review?
Make the decision concrete
Bring these three checks to the shortlist. If an answer describes another product, a different payment period, or a service you are not eligible for, the comparison is not finished.
- Confirm that the headline you use belongs to the proposed product rather than a separate microdosing offer.
- Request the named product, total initial payment, and next renewal in the same written quote.
- Confirm how the receiving clinician reviews existing treatment and how questions are handled between orders.
Separate the product from the provider
FDA approval belongs to a particular drug product, not to a review site’s list or a telehealth brand. A compounded preparation has not received that approval. Ingredient similarity does not establish the same route, formulation, manufacturing controls, or evidence.
Ask the clinician why the exact prescription fits your medical needs. Then ask the pharmacy for the label and instructions appropriate to that product. Read what compounding and FDA approval mean if those terms are being used interchangeably in a promotion.
Before accepting another offer
Keep the current agreement, prescription label, and any pending order information together. A new enrollment does not automatically stop the previous company’s next charge or authorize a continuation prescription.
Use the questions-before-purchase checklist to record the answers in your own words. A useful next step is a clear conversation and a complete proposal, not a decision based on a rank alone.
Source notes
Provider material describes the company’s own offer. Official medical references explain clinical and regulatory context; they do not endorse this publication or its commercial partner.
- CoreAge Rx: official treatment overview ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: current sale offer ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: plan billing explained ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: contact and professional-entity disclosures ↗Provider-published information · Checked September 22, 2026
- CoreAge Rx: purchasing process ↗Provider-published information · Checked September 22, 2026
- NiceRx: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- Brightmeds: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- Lean Meds: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- GLP-1 Weight Loss Treatment | Henry ↗Provider-published information · Checked September 22, 2026
- Weight Loss - Ro Body Membership | Ro ↗Provider-published information · Checked September 22, 2026
- Ro - Telehealth for ED, Hair loss, Skincare, Fertility and More ↗Provider-published information · Checked September 22, 2026
- Ivy Rx: official program, pricing, and care details ↗Provider-published information · Checked September 22, 2026
- FDA: concerns with unapproved GLP-1 drugs ↗Regulatory / public agency · Checked September 22, 2026
- FDA: risks of compounded drugs ↗Regulatory / public agency · Checked September 22, 2026